Table 5 Comparison of medication usage
Patients with persistently impaired CAVI | Patients with improved CAVI | P-value | |
|---|---|---|---|
Medications at first CAVI test, n (%) | |||
Statins, n (%) | 50 (48) | 55 (52) | 0.5 |
ACEIs/ARBs, n (%) | 48 (46) | 57 (55) | 0.2 |
CCBs, n (%) | 35 (34) | 31 (30) | 0.5 |
Beta-blockers, n (%) | 27 (26) | 21 (20) | 0.3 |
Aspirin, n (%) | 61 (58) | 63 (61) | 0.7 |
Oral antidiabetic agents, n (%) | 45 (43) | 32 (30) | 0.06 |
Insulin, n (%) | 11 (10) | 9 (8.5) | 0.6 |
Medications at second CAVI test, n (%) | |||
Statins, n (%) | 77 (73) | 84 (80) | 0.3 |
ACEIs/ARBs, n (%) | 56 (50) | 66 (63) | 0.3 |
CCBs, n (%) | 40 (38) | 37 (35) | 0.6 |
Beta-blockers, n (%) | 35 (33) | 27 (25) | 0.2 |
Aspirin, n (%) | 61 (58) | 63 (61) | 0.2 |
Oral antidiabetic agents, n (%) | 46 (44) | 35 (33) | 0.1 |
Insulin, n (%) | 13 (12) | 10 (9.4) | 0.5 |
